Empirical Finance, LLC Astrazeneca PLC Transaction History

Empirical Finance, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 05, 2023	SELL	$63.15 - $71.6 $1,010 - $1,145	-16 Reduced 0.52%	3,053 $211,000
Q4 2022 Jan 24, 2023	BUY	$54.21 - $70.44 $166,370 - $216,180	3,069 New	3,069 $208,000
Q1 2022 Apr 21, 2022	SELL	$55.72 - $67.12 $10,865 - $13,088	-195 Reduced 5.11%	3,618 $240,000
Q4 2021 Feb 04, 2022	SELL	$54.02 - $63.83 $12,316 - $14,553	-228 Reduced 5.64%	3,813 $222,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $224,517 - $245,652	4,041 New	4,041 $243,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

Stay updated on Empirical Finance, LLC with notifications on news.